Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1482-2025

Hemopore 2PK nasal/sinus temporary wound dressing, Catalog Number 5400-222-208S Recall

Hemopore 2PK nasal/sinus temporary wound dressing, Catalog Number 5400-222-208S

FDA recall Class II

Ongoing

FDA lists this Class II recall for Hemopore 2PK nasal/sinus temporary wound dressing, Catalog Number 5400-222-208S. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1482-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Feb 25, 2025
FDA report date
Apr 9, 2025
Quantity in commerce
182,344 total units
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

Hemopore 2PK nasal/sinus temporary wound dressing, Catalog Number 5400-222-208S

Affected model & UDI checker

Search the exact identifiers published for Z-1482-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
5400-222-208SHemopore 2PK nasal/sinus temporary wound dressing, Catalog Number 5400-222-208SCheck source noticeNot specified
Not specifiedHemopore 2PK nasal/sinus temporary wound dressing, Catalog Number 5400-222-208SCheck source notice07613327500486
FDA code information

5400-222-208S UDI-DI: 07613327500486, Lot Numbers: 2024020221 2024051720 2024082321

View the original FDA recall notice

Why was this product recalled?

There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that the sterility seal has been breached.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Stryker Corporation take?

An Urgent Medical Device Recall notification letter dated 2/24/25 was sent to customers. Actions to be taken 1. Immediately review your inventory to locate and quarantine any affected products at your facility. 2. Return the enclosed Business Reply Form (BRF), even if the affected product is no longer in inventory, to the email Instruments.Recalls@stryker.com. 3. Upon receipt of the completed BRF, Stryker will provide a shipping label to return recalled product on-hand. 4. A replacement will be provided upon receipt of the recalled product. 5. Maintain awareness of this communication internally and inform Stryker if any of the subject devices have been distributed to other organizations. If so, provide contact details so Stryker can inform the recipients accordingly. Instruments.recalls@stryker.com. RESPONSE IS REQUIRED.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology